期刊文献+

IGF-Ⅱ mRNA、bcl-2蛋白在结肠直肠腺癌组织中的表达及临床意义 被引量:3

Expression and Clinical Significance of IGF-Ⅱ mRNA and Bcl-2 Protein in Colorectal Adenocarcinomas
暂未订购
导出
摘要 背景与目的:胰岛素样生长因子-Ⅱ(Insulin-likegrowthfactorⅡ,IGF-Ⅱ)能促进细胞分裂、增殖,B细胞淋巴瘤-2(bcl-2)蛋白能明显抑制细胞的凋亡,使细胞寿命延长。近来发现两者在结肠直肠癌中均存在过表达,但两者在结肠直肠癌中的联合检测尚未见报道。本文通过观察结肠直肠腺癌中IGF-ⅡmRNA、bcl-2蛋白的表达情况,结合肿瘤中细胞增殖和凋亡状态的研究,探讨IGF-Ⅱ,bcl-2基因表达的相关性以及与结肠直肠腺癌浸润、转移的关系,并探求两者联合检测的临床意义。方法:选取48例结肠直肠腺癌石蜡标本,采用原位分子杂交检测IGF-ⅡmRNA,S-P法检测bcl-2蛋白,增殖细胞核抗原(PCNA),TUNEL法检测细胞凋亡,多媒体图文分析系统定量肿瘤阳性细胞率。以10例正常结肠直肠组织作为对照。结果:结肠直肠腺癌中IGF-ⅡmRNA,bcl-2蛋白阳性细胞率犤(38.70±7.80)%和(30.97±7.40)%犦均显著高于正常结肠直肠组织犤(23.12±4.07)%和(12.69±1.31)%犦(P<0.01),IGF-ⅡmRNA和bcl-2蛋白表达呈负相关(P<0.05),且均与肿瘤Dukes'分期有关和淋巴结转移有关,而与患者的年龄,性别,肿瘤大小,部位,分化程度无关。IGF-ⅡmRNA与PCNA,细胞凋亡显著正相关(P<0.01),bcl-2蛋白与细胞凋亡显著负相关(P<0.01),而与PCNA表达无关(P>0.05)。 Background & Objective: Insulin like growth factor Ⅱ (IGF Ⅱ) can stimulate cell proliferation; B cell lymphoma 2 (bcl 2) protein can strongly inhabit cell apoptosis. Recently, the overexpression of IGF Ⅱ and bcl 2 in colorectal cancer has been found,but the combined detection of them has not been reported. The objective of this study was to investigate the relationship between the expression of IGF Ⅱ, bcl 2 and the invasion,metastases of colorectal adenocarcinomas and to analyze the clinical significance of combined detection of these factors. Methods: Forty eight paraffin embedded samples from colorectal adenocarcinomas were selected. IGF Ⅱ mRNA was detected by using in situ hybridization. The expressions of bcl 2 and PCNA protein were determined immunohistochemically,and TUNEL technique was used to detect apoptosis. Ten normal colorectal tissues were used as controls. The positive cell ratio of cancers was calculated by computer. The specimens with positive cell ratio ≤30% were defined as negative. Results: The expressions of IGF Ⅱ mRNA and bcl 2 protein were significantly higher in colorectal adenocarcinomas (38.70%±7.80% and 30.97%±7.40%) than in normal colorectal tissues(23.12%±4.07% and 12.69%±1.31%)(P< 0.01) and were related to Dukes′ stage and lymph node metastases but were not associated with patient′s age, gender, tumor site, tumor size and umor differentiation. A negative correlation was observed between IGF Ⅱ mRNA and bcl 2 protein (P< 0.05). A positive correlation between IGF Ⅱ mRNA and PCNA, apoptosis as well as a negative correlation between bcl 2 and apoptosis were observed (P< 0.01).There was no correlation between bcl 2 and PCNA (P >0.05). The patients with IGF Ⅱ mRNA (+) and bcl 2 ( ) were regarded as the worst prognosis. Conclusion: The overexpression of IGF Ⅱ and bcl 2 in colorectal adenocarcinomas play an important role in the pathogenesis,progression, invasion, and metastases of the tumor. Determination of both IGF Ⅱ and bcl 2 expression would be helpful for decision making of adjuvant therapy.
出处 《癌症》 SCIE CAS CSCD 北大核心 2002年第11期1226-1230,共5页 Chinese Journal of Cancer
关键词 IGF-Ⅱ bcl-2 直肠腺癌 原位杂交 结肠腺癌 IGF Ⅱ bcl 2 Colorectal adenocarcinomas In situ hybridization
  • 相关文献

参考文献16

  • 1Kawamoto K, Onodera H, Kan S, et al. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma [J]. Cancer, 1999,85(1): 18- 25.
  • 2Alexandra G, George PS, Eleni T, et al. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma [J]. Cancer, 1999, 86(8): 1421- 1430.
  • 3Mohan S, Jennings JC, Linkhart TA, et al. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-Ⅱ [J]. Biohim Biophys Acta, 1988,966(1): 44- 55.
  • 4Berger A. Insulin-like growth factor and cognitive function [J]. BMJ, 2001,322(1):203.
  • 5Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation [J]. Science, 1984, 226: 1097- 1099.
  • 6Hockenbery D, Nunez G, Milliman C, et al. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death [J]. Nature, 1990,348:334- 336.
  • 7Lee AV, Darbre P, King RJ. Processing of insulin-like growth factor-Ⅱ (IGF-Ⅱ ) by human breast cancer cells [J]. Mol Cell Endocrinol, 1994,99:211- 220.
  • 8Cariani E, Lasserre C, Seurin D, et al. Differential expression of insulin-like growth factorⅡ mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis [J]. Cancer Res, 1988,48:6844- 6849.
  • 9Hoppner JWN, Mosselman S, Roholl PJM, et al. Expression of insulin-like growth factor-Ⅰ and -Ⅱ renes in human smooth muscle tumors [J]. EMBO J,1988,7:1379- 1385.
  • 10Tricoli JV, Rall LB, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas [J]. Cancer Res, 1986,46: 6169- 6173.

同被引文献15

  • 1李雪莲,李锦玉.胰岛素样生长因子-1受体与肿瘤的研究进展[J].国外医学(妇幼保健分册),2005,16(6):435-437. 被引量:4
  • 2万云乐,丁伟,郑树森,闵军,王捷.原发性胆囊癌Survivin和Ki-67的表达及意义[J].中华实验外科杂志,2006,23(8):919-921. 被引量:17
  • 3Liu B, Han M,Wen JK, et al. Livin/ML-IAP as a new target for cancer treatment. Cancer Lett,2007,250 : 168-176.
  • 4Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging:changing cancer staging by analysis of data from the National. Cancer Database. Ann Surg,2006,243:767-774.
  • 5Wang TS, Ding QQ, Guo RH, et al. Expression of' livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene. Biomed Phannacother,2010,64:333-338.
  • 6Wang L,Zhang Q, Liu B,et al. Challenge and promise:roles for Livin in progression and therapy of cancer. Mol Cancer Ther,2008 ,7 :3661-3669.
  • 7Daughaday W H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of humantumois(editorial). Endocrinology, 1990, 127(1):1-4.
  • 8Chen SC. Overexpression of epidermal growth factor and insulinlilke, growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells. Cancer Res, 1991,51 (7): 1898-1903.
  • 9AI-Kasspooles M, Moore JH, Orringer MB. Amplification and overexpression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer, 1993,54(2):213-219.
  • 10Imsumran A, Adachi Y, Yamamoto H. Insulin-mike growth factor-1 receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma.Carcinogenesis, 2007, 28(5):947-956.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部